Skip to main content
. 2023 Jun 14;18(6):e0286303. doi: 10.1371/journal.pone.0286303

Fig 1. Proportion of CALHIV ages 2–18 years receiving MMD among those currently on ART at 36 SIDHAS-supported sites in Akwa Ibom and Cross River states, Nigeria, by quarter (October 2019–March 2021).

Fig 1